Ranganathan Ram is a Psychiatry physician. OpenAlex indexes 12 publications with 469 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 Foulk Rd Ste 106
Wilmington, DE 198033835
Telephone
302-762-2285Provider last certified this registry record 9 Aug 2021.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Axsome Therapeutics, Inc.Program year20251 payment
- Janssen Pharmaceuticals, IncProgram year20242 payments
- Axsome Therapeutics, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine29%Alprazolam61%Clonazepam19%Lorazepam12%Alprazolam Er8%Part D<11 patientsSSRI15.7%Escitalopram Oxalate43%Trazodone Hcl38%Sertraline Hcl18%Part D<11 patients+ 9 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Suspiciousness as a specific risk factor for major depressive episodes in schizophrenia
Schizophrenia Research
2001 - Diagnosis, treatment, and six-month outcome status in first-admission psychosis.
Annals of Clinical Psychiatry
1997 - Diagnosis, Treatment, and Six-Month Outcome Status in First-Admission Psychosis
Annals of Clinical Psychiatry
1997
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”